HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Limitation of infarct size by trimetazidine in the rabbit.

Abstract
The influence of trimetazidine on infarct size was studied with a 45-minute period of coronary occlusion followed by 24 hours of blood reperfusion in the rabbit heart. The groups studied were 7 control rabbits and 7 rabbits pretreated with 3 mg/kg of trimetazidine. Twenty-four hours after coronary artery ligation for 45 minutes, infarct size was measured in myocardial slices using trinitrophenyl tetrazolium staining, and the area at risk was determined by injection of zinc/cadmium particles and delineated at the same time by imaging, under fluorescent light, the areas of tissue that fluoresced. The range of area at risk was similar in both of the groups. There was a significant reduction in the size of infarct that developed in the trimetazidine-treated group when compared with the control rabbits. It is concluded that pretreatment with trimetazidine in the blood-perfused rabbit heart is effective in reducing myocardial infarct size.
AuthorsM I Noble, P R Belcher, A J Drake-Holland
JournalThe American journal of cardiology (Am J Cardiol) Vol. 76 Issue 6 Pg. 41B-44B (Aug 24 1995) ISSN: 0002-9149 [Print] United States
PMID7645528 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Trimetazidine
Topics
  • Animals
  • Female
  • Myocardial Infarction (physiopathology, prevention & control)
  • Rabbits
  • Trimetazidine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: